Holen Sie sich die Stockscreener-App
11.03
3.08%
-0.35
Handel nachbörslich:
11.21
0.18
+1.63%
Schlusskurs vom Vortag:
$11.38
Offen:
$11.28
24-Stunden-Volumen:
4,679
Relative Volume:
0.18
Marktkapitalisierung:
$53.35M
Einnahmen:
$2.61M
Nettoeinkommen (Verlust:
$1.69M
KGV:
36.73
EPS:
0.3003
Netto-Cashflow:
-
1W Leistung:
+10.30%
1M Leistung:
+18.73%
6M Leistung:
+54.69%
1J Leistung:
+27.66%
1-Tages-Spanne:
$10.26
$11.28
1-Wochen-Bereich:
$9.5309
$11.38
52-Wochen-Spanne:
$6.55
$11.38
Daxor Corporation Stock (DXR) Company Profile
Firmenname
Daxor Corporation
Sektor
Telefon
212-330-8500
Adresse
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Vergleichen Sie DXR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
11.03 | 50.07M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
288.28 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.48 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-05-16 | Eingeleitet | Ascendiant Capital Markets | Buy |
Daxor Corporation Aktie (DXR) Neueste Nachrichten
How high can Daxor Corporation stock price go in 2025Weekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
Key resistance and support levels for Daxor CorporationJuly 2025 PostEarnings & Reliable Price Breakout Alerts - Newser
Will Daxor Corporation continue its uptrendFree AI Driven Stock Trend Forecast - Newser
Is Daxor Corporation a candidate for recovery playFree AI Driven Stock Trend Forecast - Newser
Can machine learning forecast Shimmick Corporation recoverySafe Momentum Strategy With Trend Analysis - Newser
Using economic indicators to assess Daxor Corporation potentialWeekly Gain Forecast with Momentum Indicators - Newser
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available - GlobeNewswire
Daxor BVA Gets FDA Clearance, Celebrates Nasdaq Listing Milestone - AInvest
Revolutionary Hand-Held Blood Volume Analyzer Gets FDA Green Light: Daxor's Game-Changing Medical Innovation - Stock Titan
Financial Survey: DaVita (NYSE:DVA) vs. Daxor (NASDAQ:DXR) - Defense World
Will Daxor Corporation stock recover after recent dropHistorical Volatility and Pattern Breakdown Analysis - Newser
Daxor Corporation shares fall 8.83% after-hours despite FDA clearance for new Blood Volume Analyzer. - AInvest
Is a relief rally coming for Tamboran Resources Corporation holdersLong-Term Stock Growth Forecast Insights - Newser
Published on: 2025-08-12 05:36:50 - Newser
Real time social sentiment graph for Amphenol CorporationIntraday Signal Forecast for Fast Traders - Newser
How Daxor Corporation stock performs during market volatilityStock Market Trend and Pattern Analysis - Newser
What’s the recovery path for long term holders of Daxor CorporationRisk-Managed Strategy Based on Price Analysis - Newser
Can volume confirm reversal in Daxor CorporationFree Stock Selection With High Accuracy - Newser
Why Daxor Corporation stock attracts strong analyst attentionPrice Movement and Market Sentiment Analysis - Newser
Applying chart zones and confluence areas to Daxor CorporationFree Capital Preserving Trade Plan Templates - Newser
Daxor Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low Capital High Return Stock Plans - Newser
Chart based analysis of Daxor Corporation trendsYearly Trend Summary and Opportunity Breakdown - Newser
What makes Daxor Corporation stock price move sharplySmart Money Strategy for Growth Stocks - Newser
Daxor Corporation Rings the Closing Bell - Nasdaq
Applying Wyckoff theory to Daxor Corporation stockCapital Safe Picks with Consistent Gains - Newser
Identifying reversal signals in Daxor CorporationSwing Trade Picks with High Potential - Newser
Tick level data insight on Daxor Corporation volatilityLong-Term Growth Trend Summary With Confidence - Newser
Daxor Corporation shares rise 4.40% intraday after FDA clearance for new Blood Volume Analyzer. - AInvest
Daxor (NASDAQ: DXR) Stock Rises After FDA Clears Breakthrough Blood Volume Analyzer for Clinical Care | DXR Stock Price - paginasiete.bo
Daxor Gains FDA Clearance for Blood Volume Analyzer - TipRanks
Daxor receives FDA clearance for next-gen blood volume analyzer By Investing.com - Investing.com Nigeria
Daxor receives FDA clearance for next-gen blood volume analyzer - Investing.com
Daxor stock soars after FDA clearance for new blood volume analyzer By Investing.com - Investing.com South Africa
Daxor stock soars after FDA clearance for new blood volume analyzer - Investing.com Nigeria
Daxor Corporation Announces FDA Clearance for Revolutionary Blood Volume Analyzer to Improve Patient Outcomes - Quiver Quantitative
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System - GlobeNewswire
Breakthrough: FDA Approves Game-Changing Blood Volume Analyzer That Cuts Mortality by 86% - Stock Titan
Has Daxor Corporation found a price floorPre-Market Stock Movement Summary and Review - Newser
Finanzdaten der Daxor Corporation-Aktie (DXR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):